ICICI Prudential US Bluechip Equity Fund Direct Growth

ICICI Prudential US Bluechip Equity Fund Direct Growth is an equity fund. This fund was started on 2 January, 2013. The fund is managed by Rohan Maru. The fund could potentially beat inflation in the long-run.

1. ICICI Prudential US Bluechip Equity Fund Direct Growth has ₹3171 Cr worth of assets under management (AUM) as on Jul 2024 and is more than category average.
2. The fund has an expense ratio 1.1.
   

ICICI Prudential US Bluechip Equity Fund Direct Growth has given a CAGR return of 17.13% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 19.42%, 12.45% and 18.53% respectively.

ICICI Prudential US Bluechip Equity Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Industrial, Tech, Consumer Defensive, Consumer Cyclical, Basic Materials, Financial Services, Communication. Its top holdings are International Flavors & Fragrances Inc, Gilead Sciences Inc, MarketAxess Holdings Inc, Veeva Systems Inc Class A, Comcast Corp Class A

As it is a global - other mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential US Bluechip Equity Fund Direct Growth has no lock in period.